Prelude Capital Management, LLC Haemonetics Corp Transaction History

Prelude Capital Management, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$71.24 - $85.35 $52,931 - $63,415	743 Added 23.28%	3,935 $335,000
Q4 2023 Feb 14, 2024	SELL	$80.59 - $92.61 $116,855 - $134,284	-1,450 Reduced 31.24%	3,192 $272,000
Q3 2023 Nov 14, 2023	BUY	$82.56 - $93.49 $383,243 - $433,980	4,642 New	4,642 $415,000
Q2 2022 Aug 15, 2022	SELL	$49.27 - $66.08 $436,384 - $585,270	-8,857 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$43.77 - $63.22 $387,670 - $559,939	8,857 New	8,857 $560,000
Q4 2021 Feb 14, 2022	SELL	$49.55 - $74.59 $661,591 - $995,925	-13,352 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$57.6 - $70.59 $134,841 - $165,251	-2,341 Reduced 14.92%	13,352 $943,000
Q2 2021 Aug 16, 2021	SELL	$51.81 - $118.56 $373,239 - $854,106	-7,204 Reduced 31.46%	15,693 $1.05 Million
Q1 2021 May 17, 2021	BUY	$111.01 - $139.48 $618,214 - $776,764	5,569 Added 32.14%	22,897 $2.54 Million
Q4 2020 Feb 16, 2021	BUY	$88.75 - $119.95 $1.07 Million - $1.45 Million	12,091 Added 230.88%	17,328 $2.06 Million
Q3 2020 Nov 16, 2020	BUY	$75.65 - $93.58 $38,278 - $47,351	506 Added 10.7%	5,237 $457,000
Q2 2020 Aug 14, 2020	BUY	$84.96 - $118.91 $401,945 - $562,563	4,731 New	4,731 $424,000
Q1 2020 May 15, 2020	SELL	$74.34 - $121.82 $8,251 - $13,522	-111 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$114.37 - $129.46 $12,695 - $14,370	111 New	111 $13,000

332

53.8M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.87B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.